GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Er-Kang Pharmaceutical Co Ltd (SZSE:300267) » Definitions » Degree of Operating Leverage

Hunan Er-Kang Pharmaceutical Co (SZSE:300267) Degree of Operating Leverage : -3.46 (As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Hunan Er-Kang Pharmaceutical Co Degree of Operating Leverage?

Degree of Operating Leverage (DOL) measures the percentage change in EBIT for a unit change in Revenue. Hunan Er-Kang Pharmaceutical Co's Degree of Operating Leverage for the quarter that ended in Mar. 2025 was -3.46. The higher Degree of Operating Leverage, the higher operating risk the company will take.

The industry rank for Hunan Er-Kang Pharmaceutical Co's Degree of Operating Leverage or its related term are showing as below:

SZSE:300267's Degree of Operating Leverage is ranked better than
76.42% of 950 companies
in the Drug Manufacturers industry
Industry Median: 0.64 vs SZSE:300267: -3.46

Hunan Er-Kang Pharmaceutical Co Degree of Operating Leverage Historical Data

The historical data trend for Hunan Er-Kang Pharmaceutical Co's Degree of Operating Leverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Er-Kang Pharmaceutical Co Degree of Operating Leverage Chart

Hunan Er-Kang Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Degree of Operating Leverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.65 79.66 6.30 201.40 -2.70

Hunan Er-Kang Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Degree of Operating Leverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.57 21.10 38.44 -2.70 -3.46

Competitive Comparison of Hunan Er-Kang Pharmaceutical Co's Degree of Operating Leverage

For the Drug Manufacturers - Specialty & Generic subindustry, Hunan Er-Kang Pharmaceutical Co's Degree of Operating Leverage, along with its competitors' market caps and Degree of Operating Leverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hunan Er-Kang Pharmaceutical Co's Degree of Operating Leverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hunan Er-Kang Pharmaceutical Co's Degree of Operating Leverage distribution charts can be found below:

* The bar in red indicates where Hunan Er-Kang Pharmaceutical Co's Degree of Operating Leverage falls into.


;
;

Hunan Er-Kang Pharmaceutical Co Degree of Operating Leverage Calculation

Hunan Er-Kang Pharmaceutical Co's Degree of Operating Leverage for the quarter that ended in Mar. 2025 is calculated as:

Degree of Operating Leverage=% Change in EBIT**/% Change in Revenue
=( -354.633 (Mar. 2025) / -211.759 (Mar. 2024) - 1 )/( 1217.371 (Mar. 2025) / 1511.982 (Mar. 2024) - 1 )
=0.6747/-0.1949
=-3.46***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of EBIT and Revenue was used to calculate Degree of Operating Leverage.
*** Please be aware that the Degree of Operating Leverage calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Hunan Er-Kang Pharmaceutical Co  (SZSE:300267) Degree of Operating Leverage Explanation

Degree of Operating Leverage (DOL) is a leverage ratio that measures the sensitivity of a company’s operting income, also referred to as Earnings Before Interest and Taxes (EBIT), to fluctuations in its Revenue. DOL is a method used to quantify a company’s operating risk. This risk is related to the company's structure of variable costs and fixed costs. Since the fixed costs do not allow the company to adjust the operating costs, the operating risk rises with a higher fixed-to-variable costs proportion.

A high Degree of Operating Leverage indicates that the company’s fixed costs exceed its variable costs. By increasing the sales, the company can earn more profits. In addition, the company must be able to maintain relatively high sales to cover all fixed costs.

Be Aware

The use of operating leverage varies across different industries and business sectors, and the application of Degree of Operating Leverage (DOL) should be adjusted accordingly.


Hunan Er-Kang Pharmaceutical Co Degree of Operating Leverage Related Terms

Thank you for viewing the detailed overview of Hunan Er-Kang Pharmaceutical Co's Degree of Operating Leverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Hunan Er-Kang Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Kangping Road 167, National Economic and Technological Development Zone, Liuyang Changsha, Hunan, CHN, 410331
Hunan Er-Kang Pharmaceutical Co Ltd develops, produces and sells pharmaceutical products in China. The company's main products include pharmaceutical excipients and antibiotics. It offers pharmaceutical excipients, APIs and finished drug products. The pharmaceutical excipients include products such as glycerol, ethanol pharmaceutically, acceptable propylene glycol, sodium hydroxide, and pharmaceutically acceptable sugar. The company's finished drugs primarily include sulbenicillin sodium for injection and compound liquorice tablets. Its APIs include glycerin, dilute hydrochloric acid, dihydroxypropyl theophylline, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. Geographically, all the activities are carried out through China.
Executives
Shuai Fang Wen Director
Wang Jun Wen Independent director
Zuo Tian Fang Independent director
Qi Yang Supervisors
Li Yi Guo Supervisors
Chen Wen Xian Supervisors
Wang Xiang Feng Directors, executives
Liu Ai Jun Directors, executives
Luo Lang Directors, executives
Fan Yi Securities Affairs Representative
Yang Hai Ming Directors, executives
Shuai You Wen Director
Shuai Rui Wen Director
Gao Zhen Ya Executives
Cao Zai Yun Director

Hunan Er-Kang Pharmaceutical Co Headlines

No Headlines